Patent details

EP2542580 Title: ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS

Basic Information

Publication number:
EP2542580
PCT Application Number:
EP2011001090
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117087163
PCT Publication Number:
WO2011107291
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS
French Title of Invention:
ANTICORPS ANTI-PHOSPHORYLCHOLINE EN POLYTHÉRAPIE DOTÉ DES AGENTS BIOLOGIQUES
German Title of Invention:
ANTIKÖRPER GEGEN PHOSPHORYLCHOLIN FÜR EINE KOMBINATIONSTHERAPIE MIT BIOLOGISCHEN WIRKSTOFFEN
SPC Number:

Dates

Filing date:
04/03/2011
Grant date:
04/08/2021
EP Publication Date:
09/01/2013
PCT Publication Date:
09/09/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2021
EP B1 Publication Date:
04/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/03/2022
Expiration date:
04/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/07/2021
 
 

Name:
Athera Biotechnologies AB
Address:
Business Center S:t Eriksgatan 117, 113 43 Stockholm, Sweden (SE)

Inventor

Name:
FROSTEGARD, Johan
Address:
Sweden (SE)

Priority

1

Priority Number:
310519 P
Priority Date:
04/03/2010
Priority Country:
United States (US)

2

Priority Number:
349410 P
Priority Date:
28/05/2010
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/18; G01N 33/564; G01N 33/68;

Publication

European Patent Bulletin

Issue number:
202131
Publication date:
04/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages